Forty-three contributors discussing the most relevant information available regarding the origins and treatment of schizophrenia through antipsychotic drugs. Because research in molecular biology has introduced some interesting alternatives to dopamine therapies, the merits of other antipsychotic drugs are examined including serotonin mechanisms but also ranging into various clinical developments with Risperidone, and comparative studies in Haloperidol. Other essays concentrate on issues in treatment such as negative side effects, and guidelines for use. Annotation c. by Book News, Inc., Portland, Or.